Highlights
• 3D bioprinting enables the fabrication of vascularized skin analogues through the precise layer-by-layer deposition of materials and cells.
• Design of ink formulations for vascularized skin analogues should consider material composition, cross-linking modifications, incorporation of angiogenic agents and heterogeneous cell sources to mimic the content of the natural extracellular matrix.
• Despite recent progress, challenges on the path to clinical translation include optimizing bioprinting techniques and ink formulations, achieving stable and functional vascular networks and scaling up bioprinted constructs.
京公网安备11010802044758号
Comments on this article